Cargando…
Utility of Elevated Pentraxin-3 Level as Inflammatory Marker for Predicting Adverse Outcomes in Patients With Acute Coronary Syndrome: A Meta-Analysis
BACKGROUND: Vascular inflammation plays an important role in the pathogenesis and development of acute coronary syndrome (ACS). However, studies on the association between elevated pentraxin-3 level and adverse outcomes in patients with ACS have yielded controversial results. The purpose of this met...
Autores principales: | Fan, Yu, He, Rong, Man, Changfeng, Gong, Dandan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811025/ https://www.ncbi.nlm.nih.gov/pubmed/35127844 http://dx.doi.org/10.3389/fcvm.2021.736868 |
Ejemplares similares
-
Higher Plasma Pentraxin-3 Level Predicts Adverse Clinical Outcomes in Patients With Coronary Artery Disease: A Meta-Analysis of Cohort Studies
por: Ding, Kejun, et al.
Publicado: (2022) -
Associations between pentraxin 3 and severity of coronary artery disease
por: Liu, Hua, et al.
Publicado: (2015) -
Elevated Serum Levels of Soluble ST2 Are Associated With Plaque Vulnerability in Patients With Non-ST-Elevation Acute Coronary Syndrome
por: Luo, Guqing, et al.
Publicado: (2021) -
Anti-inflammatory Therapies for Coronary Heart Disease: A Systematic Review and Meta-Analysis
por: Wang, Haiming, et al.
Publicado: (2021) -
Addition of TyG index to the GRACE score improves prediction of adverse cardiovascular outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: A retrospective study
por: Pang, Shuo, et al.
Publicado: (2022)